Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-20-034010)

Filing Details

Accession Number:: 0001209191-20-034010
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-06-03 16:26:32
Reporting Period:: 2020-05-18

Accepted Time:: 2020-06-03 16:26:32
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1515673	Ultragenyx Pharmaceutical Inc.	RARE	Pharmaceutical Preparations (2834)	272546083

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1598426	William Aliski	C/O Ultragenyx Pharmaceutical Inc. 60 Leveroni Court Novato CA 94949		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2020-05-18	20,000	$74.02	70,350	No	4	S	Indirect	By trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By trust

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	46,924	Direct
Common Stock	9,686	Indirect	By trust
Common Stock	18,000	Indirect	By trust

Footnotes

These shares are held in a trust for the benefit of the Reporting Person's spouse and children. The Reporting Person's spouse and nephew are trustees of the trust.
The amount set forth in column 5 reflects dispositions from gifts that will be reported in a Form 5 within 45 days after the Issuer's fiscal year end.
These shares are held in a grantor retained annuity trust. The Reporting Person is the trustee of the trusts.